Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any pontocerebellar hypoplasia type 1 in which the cause of the disease is a mutation in the EXOSC8 gene.
Features include always present findings: Global developmental delay, Difficulty breathing (respiratory insufficiency), and Respiratory failure; and very common findings: Hearing loss (hearing impairment) and Visual impairment. 19 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 6 | Skeletal muscle atrophy, Cerebral cortical atrophy, Joint contracture |
EXOSC8 encodes exosome component 8 (276 aa). Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. Highest expression in Cells EBV-transformed lymphocytes (60.2 TPM) and Testis (43.8 TPM).
Pontocerebellar hypoplasia, type 1C is associated with mutations in the EXOSC8 gene on chromosome 13.
EXOSC8 is classified as a druggable target with score 0.0.
Genetic testing for EXOSC8 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 3 always present features, 2 very common features, 8 common features.
No clinical trials have been registered for pontocerebellar hypoplasia, type 1C.
3 publications have been identified in PubMed for pontocerebellar hypoplasia, type 1C. Research spans Review / Meta-Analysis (67%) and Case Report / Case Series (33%).
Škarica M (2025). [PMID: 40428407](https://pubmed.ncbi.nlm.nih.gov/40428407/). *Genes (Basel)*. [Review / Meta-Analysis]
Sharifi S (2025). [PMID: 41069053](https://pubmed.ncbi.nlm.nih.gov/41069053/). *Ann Indian Acad Neurol*. [Case Report / Case Series]
Bressman ZJ (2025). [PMID: 40045779](https://pubmed.ncbi.nlm.nih.gov/40045779/). *Philos Trans R Soc Lond B Biol Sci*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:12 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Brain and nerves |
6 |
Cerebral cortical atrophy, Global developmental delay, Spastic tetraparesis |
Bones and joints | 2 | Skeletal muscle atrophy, Joint contracture |
Lungs and breathing | 2 | Difficulty breathing (respiratory insufficiency), Respiratory failure |
Ears | 1 | Hearing loss (hearing impairment) |
Digestive system | 1 | Feeding difficulties |
Growth and development | 1 | Failure to thrive |
Eyes | 1 | Visual impairment |